Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
01 1Chunghwa Chemical Synthesis & Biotech. Ltd
01 1LCZ696
01 1Taiwan
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6258
Start Marketing Date : 2016-02-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A LCZ 696 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LCZ 696, including repackagers and relabelers. The FDA regulates LCZ 696 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LCZ 696 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LCZ 696 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LCZ 696 supplier is an individual or a company that provides LCZ 696 active pharmaceutical ingredient (API) or LCZ 696 finished formulations upon request. The LCZ 696 suppliers may include LCZ 696 API manufacturers, exporters, distributors and traders.
click here to find a list of LCZ 696 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing LCZ 696 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for LCZ 696 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture LCZ 696 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain LCZ 696 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a LCZ 696 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of LCZ 696 suppliers with NDC on PharmaCompass.
We have 1 companies offering LCZ 696
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
